UA95701U - Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia - Google Patents

Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia

Info

Publication number
UA95701U
UA95701U UAA201409846U UAA201409846U UA95701U UA 95701 U UA95701 U UA 95701U UA A201409846 U UAA201409846 U UA A201409846U UA A201409846 U UAA201409846 U UA A201409846U UA 95701 U UA95701 U UA 95701U
Authority
UA
Ukraine
Prior art keywords
endothelial dysfunction
adolescents
arterial hypertension
hyperuricemia
diagnosing
Prior art date
Application number
UAA201409846U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Mykola Mykhailovych Koreniev
Liudmyla Feodosiivna Bohmat
Iryna Mykolaiivna Bessonova
Original Assignee
State Inst Institute Of Child And Adolescent Health Care Of The Nat Acad Of Medical Sciences Of Ukra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by State Inst Institute Of Child And Adolescent Health Care Of The Nat Acad Of Medical Sciences Of Ukra filed Critical State Inst Institute Of Child And Adolescent Health Care Of The Nat Acad Of Medical Sciences Of Ukra
Priority to UAA201409846U priority Critical patent/UA95701U/en
Publication of UA95701U publication Critical patent/UA95701U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for diagnosing endothelial dysfunction in adolescents with arterial hypertension comprises anthropometric and laboratory examination. Adolescent patients are checked for body mass index, the level of uric acid in the serum and the amount of venous blood plasma nitric oxide metabolites. In case of body mass index > 24.9 kg/m, the level of uric acid exceeding > 0.352 mmol/l and β-microglobulin indicators > 2.09 mg/l, the formation of endothelial dysfunction and unfavorable course of the disease is diagnosed.
UAA201409846U 2014-09-08 2014-09-08 Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia UA95701U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201409846U UA95701U (en) 2014-09-08 2014-09-08 Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201409846U UA95701U (en) 2014-09-08 2014-09-08 Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia

Publications (1)

Publication Number Publication Date
UA95701U true UA95701U (en) 2015-01-12

Family

ID=52988612

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201409846U UA95701U (en) 2014-09-08 2014-09-08 Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia

Country Status (1)

Country Link
UA (1) UA95701U (en)

Similar Documents

Publication Publication Date Title
MX361944B (en) Methods for detecting signatures of disease or conditions in bodily fluids.
EP4335932A3 (en) Methods of monitoring conditions by sequence analysis
MX2018009304A (en) Diagnostic and prognostic methods for cardiovascular diseases and events.
WO2014201516A3 (en) Biomarker identification
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
CA2863393A1 (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
EP2720043A3 (en) HMGB1 and anti-HMGB1 antibodies for the prognosis of neurological disorders
GB201201766D0 (en) Method
RU2010145662A (en) METHOD FOR PREDICTING THE RISK OF DEATH OF PATIENTS WITH CHRONIC HEART FAILURE
WO2015010042A3 (en) Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/di
UA95701U (en) Method for diagnosing endothelial dysfunction in adolescents with arterial hypertension and hyperuricemia
RU2013125276A (en) METHOD FOR PREDICTING PREECLAMPSIA IN PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY
RU2010148706A (en) METHOD FOR DETERMINING HISTAMINE INCREASE IN PREGNANT BLOOD UNDER INFLUENCE OF ARGININDEHYDROGENASE ACTIVITY GROWTH IN PLACENTA SINCITIOTROFOBLAST CAUSED BY TREASIS AGAINST THREE AREA.
RU2012144558A (en) METHOD FOR LABORATORY DIAGNOSTICS OF SEPTIC ENCEPHALOPATHY IN NEWBORNS WITH PERINATAL HYPOXIC CNS Disease
RU2013155841A (en) METHOD FOR EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE
UA80125U (en) Method for early diagnosis of nascent primary placental insufficiency
UA94058U (en) Method for diagnosing fracture healing
UA94059U (en) Method for diagnosing fracture healing
Khair et al. C52 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION I: Angiotensin Ii Type 1 Receptor Antibodies And Right Ventricular Structure And Function In Pulmonary Arterial Hypertension
UA93814U (en) A method for diagnosing syndrome of retardation of fetus development and the degree of its severity
UA78111U (en) method for diagnosis of hepatorenal syndrome in cirrhosis
Chandra et al. D39 CONNECTING THE DOTS: DRAWING LINES BETWEEN COPD AND COMORBID CONDITIONS: Humoral Autoimmunity As A Mechanism For Kidney Dysfunction In COPD
Sharma et al. A57 WHO GROUP III/IV PULMONARY HYPERTENSION: Comparison Of Efficacy Of Different Treatment Regimens In Pulmonary Hypertension Secondary To Lung Disease And/or Hypoxia
UA62777U (en) Method for early diagnosis of severity grade of renal failure of various genesis
UA80632U (en) Method for complex diagnosis of osteopenia in pregnant patients with perinatal infection